Skip to content

Transcranial Direct Current Stimulation Combined with Atomoxetine Hydrochloride in the Comprehensive Treatment of Attention Deficit Hyperactivity Disorder: A Clinical Study

Transcranial Direct Current Stimulation Combined with Atomoxetine Hydrochloride in the Comprehensive Treatment of Attention Deficit Hyperactivity Disorder: A Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104085
Enrollment
Unknown
Registered
2025-06-10
Start date
2025-04-05
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder,

Interventions

tDCS group:High-precision tDCS, targeting Fp2 and Cp6, each target was stimulated for 15 minutes
Current 1mA
Once every other day for a total of 10
Neuromodulation Sham Control Group:The target was the same as the tDCS group, but the stimulation was only 0-1 mA (30S) and 1 mA-0 (30S) and 1 mA-0 (30S) at the beginning of stimulation, during stimul
ATX group:For those with a body weight of 70 kg, and 100 mg/day for those who reach the best response in 2-4 weeks
Combined Intervention Group (tDCS + ATX):The same unit dose of ATX was administered orally at the same unit dose using the same parameter tDCS

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Children aged 1.6-12 years with 2 developmental, behavioral and/or psychiatric specialists with the title of associate professor or above diagnosed with ADHD; 2. Wechsler Intelligence Scale IQ>80, SM>=8; 3. Vanderbilt ADHD Assessment Questionnaire; QCD questionnaire; 4. No history of ADHD drug use; 5. Children and their guardians voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Comorbid other developmental and behavioral disorders or psychiatric and psychological diseases, such as comorbid autism spectrum disorder, schizophrenia, etc.; 2. Elevated intracranial pressure, head injury, metal implants in the face or skull area, cochlear implantation, brain pacemaker installation (except braces).

Design outcomes

Primary

MeasureTime frame
Correct Response Rate in Continuous Performance Test ;Go/No-go Task accuracy;N-back Task accuracy;Rule-Switching Accuracy of Global-Local Set Shifting ;Simon task accuracy;Balloon Analogue Risk Task Adjusted Pumps;Intertemporal choice task Net Score;

Secondary

MeasureTime frame
Vanderbilt ADHD Diagnostic Rating Scale Scores;Conners' Parent Rating Scale-Revised Scores;The Behavior Rating Inventory of Executive Function, Second Edition Scores;ADHD Rating Scale-IV Scores;Questionnaire of Children's Difficulties Scores;

Countries

China

Contacts

Public ContactLi Chen

Children's Hospital Affiliated to Chongqing Medical University

chenli2012@126.com+86 136 7762 0103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026